Choosing anticancer drug targets in the postgenomic era

This publication has 22 references indexed in Scilit:

• The Emerging p53 Gene Family
  JNCI Journal of the National Cancer Institute, 1999
• Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein
  Nature, 1997
• COMMENTARY: p⁵³ Tumor suppressor gene: from the basic research laboratory to the clinic—an abridged historical perspective
  Carcinogenesis: Integrative Cancer Research, 1996
• A novel form of Epstein-Barr virus latency in normal B cells in vivo
  Cell, 1995
• Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
  Cell, 1995
• Gene deletion: a new target for cancer chemotherapy
  The Lancet, 1993
• Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53
  Nature, 1993
• DNA tumor virus transforming proteins and the cell cycle
  Current Opinion in Genetics & Development, 1993
• How many mutations are required for tumorigenesis? implications from human cancer data
  Molecular Carcinogenesis, 1993
• Suppression of the Neoplastic Phenotype by Replacement of the RB Gene in Human Cancer Cells
  Science, 1988